Cargando…
Pulmonary Fibrosis in COVID-19 Recovered Patients: Problem and Potential Management
How to cite this article: B, Khanna P, Sarkar S. Pulmonary Fibrosis in COVID-19 Recovered Patients: Problem and Potential Management. Indian J Crit Care Med 2021;25(2):242–244.
Autores principales: | Kayarat, Bhavana, Khanna, Puneet, Sarkar, Soumya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922461/ https://www.ncbi.nlm.nih.gov/pubmed/33707912 http://dx.doi.org/10.5005/jp-journals-10071-23733 |
Ejemplares similares
-
Posaconazole in the Prevention of COVID-19-associated Mucormycosis: A Concerning Contributor to the Rise in Antifungal Resistance
por: Kayarat, Bhavana, et al.
Publicado: (2021) -
Superadded Coinfections and Antibiotic Resistance in the Context of COVID-19: Where do We Stand?
por: Kayarat, Bhavana, et al.
Publicado: (2021) -
Eyes Have It: From COVID-19 Perspective
por: Sarkar, Soumya, et al.
Publicado: (2020) -
In Pursuit of Freedom from COVID-19 Awareness in India: An Infodemiological Analysis
por: Sarkar, Soumya, et al.
Publicado: (2021) -
Are there pulmonary sequelae in patients recovering from COVID-19?
por: Rogliani, Paola, et al.
Publicado: (2020)